Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.
MAILBOX | CHINESE | ENGLISH
Products
API & Intermediates
Cell Signaling Pathway Inhibitors
·Inhibitors of BTK Pathway
·Inhibitors of EGFR pathways
·Inhibitors of VEGFR pathways
·Inhibitors of PDGFR pathways
·Inhibitors of PI3K-Akt-mTOR pathways
·Inhibitors of IGF pathways
·Inhibitors of JAK-STAT pathway
·Inhibitors of MAPK/ERK pathway
·Inhibitors of apoptosis pathway
·Inhibitors of HIF-1 pathway
·Inhibitors of other pathways
Small Molecule Compounds
Impurity Reference Standards
Others
Contact Us
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621
Fax: +86-531-88817925
Zip Code: 250101
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com
Cell Signaling Pathway Inhibitors Now Position:Home > Products > Cell Signaling Pathway Inhibitors < Inhibitors of apoptosis pathway
ABT-737(CAS:852808-04-9)

Product No.

TP1116A 

Name

ABT-737

Synonyms

4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide

CAS Number

852808-04-9

Structure

Brief Description

ABT-737 is a BH3 mimetic inhibitor of Bcl-xL, Bcl-2 and Bcl-w with EC50 of 78.7 nM, 30.3 nM and 197.8 nM, respectively.

Purity

>99%

Package

5mg10mg20mg50mg

 





Close
QQ1: 1762738062
QQ2: 1919147143
MSN: sales-trio
SKYPE: janisa.yan